JPMorgan Chase & Co. Issues Pessimistic Forecast for Merit Medical Systems (NASDAQ:MMSI) Stock Price

Merit Medical Systems (NASDAQ:MMSI) had its price target reduced by equities researchers at JPMorgan Chase & Co. from $95.00 to $77.00 in a research note issued on Friday,Benzinga reports. The firm presently has an “overweight” rating on the medical instruments supplier’s stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 24.33% from the stock’s current price.

Other equities analysts have also issued reports about the stock. Needham & Company LLC cut their target price on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a report on Friday. Compass Point set a $107.00 price target on shares of Merit Medical Systems in a report on Monday, April 20th. Robert W. Baird set a $83.00 price target on shares of Merit Medical Systems in a research report on Friday. Wells Fargo & Company decreased their price objective on shares of Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating for the company in a research report on Friday. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Merit Medical Systems in a research note on Friday, March 27th. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $93.30.

Merit Medical Systems Stock Performance

Shares of MMSI traded down $6.25 during mid-day trading on Friday, reaching $61.93. The company had a trading volume of 1,394,982 shares, compared to its average volume of 762,160. The stock has a market capitalization of $3.69 billion, a P/E ratio of 29.27, a PEG ratio of 1.83 and a beta of 0.64. Merit Medical Systems has a 52-week low of $61.79 and a 52-week high of $100.19. The stock has a 50 day moving average of $70.68 and a two-hundred day moving average of $79.78. The company has a quick ratio of 2.95, a current ratio of 4.34 and a debt-to-equity ratio of 0.46.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.08. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The company had revenue of $393.94 million during the quarter, compared to analysts’ expectations of $390.77 million. During the same period last year, the business earned $0.93 earnings per share. Merit Medical Systems’s quarterly revenue was up 10.9% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, analysts expect that Merit Medical Systems will post 3.61 earnings per share for the current year.

Institutional Trading of Merit Medical Systems

Institutional investors have recently modified their holdings of the stock. AQR Capital Management LLC increased its stake in shares of Merit Medical Systems by 7.3% during the first quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier’s stock worth $1,730,000 after purchasing an additional 1,114 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in Merit Medical Systems by 16.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier’s stock valued at $76,039,000 after buying an additional 103,878 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Merit Medical Systems by 745.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock valued at $86,000 after buying an additional 813 shares in the last quarter. First Trust Advisors LP boosted its holdings in Merit Medical Systems by 24.8% in the 2nd quarter. First Trust Advisors LP now owns 59,215 shares of the medical instruments supplier’s stock worth $5,535,000 after buying an additional 11,770 shares during the last quarter. Finally, Cerity Partners LLC increased its stake in Merit Medical Systems by 9.1% during the 2nd quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier’s stock worth $282,000 after buying an additional 251 shares in the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Trending Headlines about Merit Medical Systems

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Q1 results beat expectations — Merit reported non?GAAP EPS of $0.94 (vs. ~$0.84 est.) and revenue of $381.9M, up ~7% year?over?year, showing steady segment and geographic gains. The company also raised FY2026 EPS guidance to $4.010–$4.150, above consensus, which supports longer?term earnings growth assumptions. Read More.
• Positive Sentiment: Margins and cash flow improved — Non?GAAP operating margin expanded slightly to ~19.7% and free cash flow rose to $24.7M (+26%), evidence that core profitability and cash generation are intact. These metrics underpin the company’s ability to fund M&A and shareholder returns. Read More.
• Neutral Sentiment: Strategic M&A and divestiture activity — Merit acquired View Point Medical for $140M (?$90M cash at close) and sold DualCap® assets for $28M (?$25.5M cash). These moves expand imaging/marker capabilities but also change near?term cash/earnings mix. Read More.
• Neutral Sentiment: Management commentary available — Earnings call transcripts provide color on demand trends, product categories (reorganized into Foundational vs. Therapeutic), and geographic performance for investors doing deeper due diligence. Read More.
• Negative Sentiment: Analyst price?target trims and multiple pressure — Wells Fargo cut its PT to $74 and moved to Equal Weight; Needham trimmed its PT to $90 while keeping Buy, citing sector multiple compression. Those moves reduce headline upside and likely contributed to intraday selling. Read More. Read More.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.